Answers are grounded in this paper and cite their sources.
Dietary inflammatory potential may be associated with sarcopenia, but evidence is heterogeneous. We systematically reviewed associations of the Dietary Inflammatory Index (DII) and energy-adjusted DII (E-DII) with sarcopenia-related outcomes in adults. PubMed, Embase, and Web of Science were searched through 31 August 2026. Random-effects meta-analyses prioritized confirmed sarcopenia. Forty-seven eligible studies were included; 16 contributed to quantitative syntheses and six were prospective. In eight cross-sectional studies, the highest versus lowest DII/E-DII category was associated with greater odds of confirmed sarcopenia (OR = 1.75, 95% CI 1.37–2.24; I2=38.5%; 95% prediction interval 1.03–2.99). Four studies contributed to per-unit analysis (OR = 1.37, 95% CI 1.25–1.51; I2=0%; prediction interval 1.12–1.68). Component-specific evidence extended to muscle strength and physical performance. Exploratory Egger regression indicated funnel-plot asymmetry; trim-and-fill attenuated the primary categorical OR to 1.48 (95% CI 1.24–1.77) and the broad categorical OR to 1.53 (95% CI 1.34–1.76). Certainty was very low. Greater dietary inflammatory potential was associated with confirmed sarcopenia, but predominantly cross-sectional evidence, heterogeneous longitudinal findings, and potential small-study effects limit causal interpretation. Clinical application is premature; prospective cohorts with repeated dietary assessment and standardized outcomes, and intervention trials, are needed.
No takes yet. Share an insight, caveat, or question.
Vázquez‐Lorente et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: